KMPR
Kemper Corporation · Financials · Insurance - Property & Casualty
Last
$32.33
−$0.14 (−0.43%) 4:00 PM ET
Pre-market $32.32 −$0.01 (−0.03%) 8:06 PM ET
Prev close $32.47
Open $32.42
Day high $32.42
Day low $31.58
Volume 1,593,245
Avg vol 1,007,648
Mkt cap
$1.90B
P/E ratio
14.43
FY Revenue
$4.79B
EPS
2.24
Gross Margin
29.53%
Sector
Financials
AI report sections
KMPR
Kemper Corporation
No AI report section text found yet for this symbol.
Volume vs average
Intraday (cumulative)
+124% (Above avg)
Vol/Avg: 2.24×
RSI
36.65 (Weak)
Weak (30–40)
MACD momentum
Intraday
-0.01 (Weak)
MACD: 0.00 Signal: 0.01
Short-Term
-0.00 (Weak)
MACD: -1.80 Signal: -1.80
Long-Term
-0.22 (Weak)
MACD: -2.60 Signal: -2.38
Intraday trend score 58.00

Latest news

KMPR 12 articles Positive: 0 Neutral: 0 Negative: 1
Negative Benzinga • Rishabh Mishra
Stock Market Today: Dow Jones, S&P 500 Futures Climb At The Start Of Christmas Week— Kemper, Trump Media & Technology, cbdMD In Focus (UPDATED)

U.S. stock futures rose on Monday as markets enter the Christmas week with abbreviated trading. The S&P 500, Nasdaq 100, and other major indices advanced in premarket trading. Key movers included Trump Media & Technology surging on a $6 billion merger completion, Kemper tumbling after a downgrade, and cbdMD rising despite missing earnings expectations. Markets are pricing in an 80.1% probability of the Federal Reserve maintaining current interest rates.

SPY QQQ DJT DJTWW stock market futures S&P 500 Nasdaq 100
Sentiment note

Shares tumbled 6.84% following a downgrade from William Blair due to deteriorating auto insurance fundamentals.

Unknown Zacks Investment Research • Zacks Equity Research
What Makes Kemper (KMPR) a New Buy Stock

Kemper (KMPR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

KMPR
Unknown Zacks Investment Research • Zacks Equity Research
Kemper (KMPR) is a Great Momentum Stock: Should You Buy?

Does Kemper (KMPR) have what it takes to be a top stock pick for momentum investors? Let's find out.

KMPR
Unknown Zacks Investment Research • Zacks Equity Research
Compared to Estimates, Kemper (KMPR) Q1 Earnings: A Look at Key Metrics

Although the revenue and EPS for Kemper (KMPR) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

KMPR
Unknown Zacks Investment Research • Zacks Equity Research
Hartford Financial (HIG) Q1 Earnings Miss on High Expenses

Hartford Financial's (HIG) quarterly results suffer from elevated loss trends in homeowners and auto business. Higher earned premium growth partially offset the negatives.

HIG ACT KMPR HMN
Unknown Zacks Investment Research • Zacks Equity Research
Is a Beat in Store for Unum Group (UNM) This Earnings Season?

Unum Group's (UNM) first-quarter results are likely to benefit from strong persistency in the in-force business, better pricing and solid sales in most of the business segments.

UNM KMPR KNSL SKWD
Unknown Zacks Investment Research • Zacks Equity Research
Should Arch Capital (ACGL) Be in Your Kitty Before Q1 Earnings?

Arch Capital's (ACGL) first-quarter results are likely to benefit from improved premiums, aided by better pricing and new business opportunities.

ACGL KMPR KNSL SKWD
Unknown Zacks Investment Research • Zacks Equity Research
What's in Store for Prudential Financial (PRU) in Q1 Earnings?

Prudential Financial's (PRU) Q1 results are likely to reflect a rise in net investment spread income, improved reinvestment rates and higher asset management fees, offset by lower net fee income.

PRU ACT KMPR HMN
Unknown Zacks Investment Research • Zacks Equity Research
Will Cincinnati Financial (CINF) Beat Estimates in Q1 Earnings?

Cincinnati Financial's (CINF) first-quarter results are likely to reflect the impact of growth initiatives, increased exposure, better pricing and increased property casualty agency, offset by cat loss.

CINF KMPR KNSL SKWD
Unknown Zacks Investment Research • Zacks Equity Research
How to Play AON Ahead of Q1 Earnings? Will Higher Costs Shock?

AON's first-quarter results are likely to showcase a significant increase in Health Solutions revenues.

AON WTW KMPR HMN
Unknown Benzinga • Benzinga Insights
5 Analysts Assess Kemper: What You Need To Know

Across the recent three months, 5 analysts have shared their insights on Kemper (NYSE:KMPR), expressing a variety of opinions spanning from bullish to bearish. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 2 0 0 0 Last 30D 0 1 0 0 0 1M Ago 0 0 0 0 0 2M Ago 1 0 0 0 0 3M Ago 2 1 0 0 0 Insights from analysts' 12-month price targets are revealed, presenting an average target of $66.6, a high estimate of $72.00, and a low estimate of $60.00. This current average reflects an increase of 10.63% from the previous average price target of $60.20. Exploring Analyst Ratings: An In-Depth Overview The perception of Kemper by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Paul Newsome Piper Sandler Raises Overweight $72.00 $66.00 Brian Meredith UBS Raises Buy $65.00 $60.00 C. Gregory Peters Raymond James Raises Strong Buy $70.00 $60.00 Paul Newsome Piper Sandler Raises Overweight $66.00 $56.00 Brian Meredith UBS Raises Buy $60.00 $59.00 Key Insights: Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their ...Full story available on Benzinga.com

KMPR Analyst Ratings
Unknown Benzinga • Piero Cingari
Health Care Becomes Most Overweighted Sector As Hedge Funds Crowd Into Magnificent 7

Six out of the 10 largest holdings in over 700 aggregated hedge fund portfolios are increasingly concentrated towards the ‘Magnificent Seven' stocks, with Tesla being the sole exception, according to the latest report by Goldman Sachs. What Happened: Insights from Goldman Sachs’ Hedge Fund Trend Monitor, an analysis led by Ben Snider, show an overzealous preference for just several mega-caps. This enthusiasm does not mirror their market weight. The Magnificent Seven accounts for a record 13% of the aggregate hedge fund long portfolios. Yet, it remains significantly underweighted compared to a 26% collective stake in the Russell 3000 — underscoring a cautious approach towards mega-cap equities. See Also: Amazon To Join Dow Jones Industrial Average: Does Venerable Index Membership Still Matter? The concentration within hedge fund portfolios rose further, with 70% of their long positions allocated to their top 10 holdings. According to analysts, this rising concentration is partly driven by confidence in specific industries, such as artificial intelligence ...Full story available on Benzinga.com

UNP KMPR AAPL SNAP Analyst Color Equities Short Sellers Social Media
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal